Work

Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience

Year: 2026

Type: article

Abstract: A real-world experience on dose reduction of ibrutinib in chronic lymphocytic leukemia is reported.

Source: Mediterranean Journal of Hematology and Infectious Diseases

DOI: 10.4084/mjhid.2026.090

Author: Roberta Laureana

Institution: St. Eugenio Hospital

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $647

OpenAlex ID: W7225016001

FWCI:

Cites: 19

Cited by:

Related to: 10